Funding Rounds
Cytovale

Cytovale October 2024 Series D Funding Round

Cytovale

Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $100.00M

Raised Date: 2024-10-10

Investors